NEOGENOMICS INC's ticker is and the CUSIP is 64049MAA8. A total of 20 filers reported holding NEOGENOMICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,656,130 | +4.0% | 28,270,000 | +3.9% | 0.57% | +6.3% |
| Q2 2023 | $25,633,336 | +4.3% | 27,216,000 | +3.8% | 0.54% | +9.8% |
| Q1 2023 | $24,565,230 | +15.0% | 26,216,000 | +4.9% | 0.49% | -4.1% |
| Q4 2022 | $21,363,997 | -1.4% | 25,003,000 | 0.0% | 0.51% | +2.6% |
| Q3 2022 | $21,663,000 | +2.4% | 25,003,000 | 0.0% | 0.50% | +4.2% |
| Q2 2022 | $21,148,000 | -35.6% | 25,003,000 | -9.1% | 0.48% | -30.6% |
| Q4 2021 | $32,819,000 | -19.7% | 27,500,000 | 0.0% | 0.69% | -26.8% |
| Q3 2021 | $40,854,000 | +4.1% | 27,500,000 | 0.0% | 0.94% | +10.0% |
| Q2 2021 | $39,254,000 | +30.3% | 27,500,000 | +37.5% | 0.85% | +9.8% |
| Q1 2021 | $30,123,000 | +131.6% | 20,000,000 | +150.0% | 0.78% | +112.0% |
| Q4 2020 | $13,008,000 | +30.0% | 8,000,000 | 0.0% | 0.37% | -4.2% |
| Q3 2020 | $10,004,000 | +16.0% | 8,000,000 | 0.0% | 0.38% | -2.1% |
| Q2 2020 | $8,624,000 | – | 8,000,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 28,000,000 | $26,250,000 | 0.83% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 28,270,000 | $26,656,130 | 0.57% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 25,499,000 | $23,905,313 | 0.56% |
| LINDEN ADVISORS LP | 37,749,000 | $34,974,463 | 0.36% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,500,000 | $5,994,495 | 0.13% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 19,019,000 | $17,830,313 | 0.08% |
| LAZARD ASSET MANAGEMENT LLC | 22,258,000 | $20,866 | 0.03% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 29,100,000 | $26,834,594 | 0.01% |
| NEW YORK STATE COMMON RETIREMENT FUND | 3,799,000 | $3,524 | 0.01% |
| JPMORGAN CHASE & CO | 395,000 | $367,638 | 0.00% |